Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000899243-17-016101

Options or other derivatives

  • Director acquired 20,739 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Phillips Gary M. Director 2017-06-08 Grant or award · Stock Option (Right to Buy) +17,776 17,776 D
Phillips Gary M. Director 2017-06-08 Grant or award · Stock Option (Right to Buy) +2,963 2,963 D
Loading xslF345X03/doc4.xml…